by John Conrad | Jun 8, 2026 | Member News
A City Club of Chicago panel put longevity science on the civic agenda — and Illinois is already positioning to lead. A few years ago, longevity science lived mostly in academic journals and Silicon Valley pitch decks. Today, it’s a topic serious enough to draw...
by John Conrad | Jun 8, 2026 | iBIO News
As part of iBIO’s partnership with GBG (Grants-to-Growth) / G2G Consulting, members continue to receive exclusive access to monthly GBG Grant Reports and funding strategy webinars designed to help organizations identify and compete for non-dilutive funding...
by John Conrad | Jun 1, 2026 | iBIO News, Policy News
The passage of HB 4327 is a significant and long-overdue win for transparency, accountability, and — most importantly — for Illinois patients. For the first time, Illinois will have an independent, standardized accounting of how the 340B program actually operates in...
by John Conrad | May 12, 2026 | Policy News
In response to the news of FDA Commissioner Dr. Marty Makary’s resignation, Illinois Biotechnology Innovation Organization (iBIO) President & CEO John Conrad issued the following statement: “The FDA plays a critical role in advancing medical innovation, protecting...
